A

APTIMMUNE BIOLOGICS, INC.

7 employees

Aptimmune is a biotechnology company that specializes on developing mucosal vaccines for swine.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Test and Measurement
Biopharma

Date founded

2010

Funding rounds raised

Total raised

$6M

from 9 investors over 9 rounds

A

APTIMMUNE BIOLOGICS, INC. raised undisclosed on January 10, 2022

Investors: The Yield Lab Asia Pacific

A

APTIMMUNE BIOLOGICS, INC. raised $6M on January 23, 2018

Investors: St. Louis Arch Angels, Cultivation Capital, Missouri Technology Corporation and The Yield Lab

A

APTIMMUNE BIOLOGICS, INC. raised $100K on August 5, 2016

Investors: The Yield Lab

A

APTIMMUNE BIOLOGICS, INC. raised $2.8M on March 24, 2016

Investors: Fox Ventures, LLC, - and Arsenal Capital Partners

FAQ